LDL cholesterol levels on the decline in the US

21 Nov 2009 - Posted by the Editorial Team

The number of adults with high levels of LDLcholesterol in the US decreased by one third between 1999 and 2006.

This is according to researchers at the Centers for Disease Control and Prevention, who also found that a high percentage of adults are still not being screened or treated for high cholesterol levels.

Using data from the US National Health and Nutrition Examination Survey, it was revealed that the prevalence of high LDL cholesterol decreased from 31.5 per cent in 1999-00 to 21.2 per cent in 2005-06.

"Self-reported use of lipid-lowering medications increased from eight per cent to 13.4 per cent, but screening rates did not change significantly, remaining less than 70 per cent during the study periods," the study authors concluded.

They went on to say that the target of improving screening rates may be hindered by a lack of consensus regarding the age at which the process should begin.

LDL is known as 'bad cholesterol' because it deposits cholesterol in the lining of the arteries, which can lead to heart disease.

Visit the Cholesterol Knowledge Centre

• High-grade prostate cancer could be prevented by low cholesterol levels 18/11/09
• Selenium supplements could increase cholesterol levels 14/11/09
• High cholesterol levels linked to arrhythmias and sudden death 27/08/09
• Body fat cannot identify high cholesterol 04/08/09
• Individuals with high cholesterol at greater risk of dementia 04/08/09

• LIPITOR
  ... inadequate. Lipitor also raises HDL-cholesterol and lowers the LDL/HDL and total cholesterol/HDL ratios. Lipitor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol, LDL-cholesterol, and apolipoprotein B in patients with homozygous familial ...
• LESCOL XL (statin)
  ... an adjunct to diet for the reduction of elevated total cholesterol (total-C), low- density lipoprotein cholesterol ( LDL-C ), apolipoprotein B (apo B) and triglycerides (TG) levels and for the increase of high-density lipoprotein cholesterol (HDL-C) in patients with primary hypercholesterolaemia and ...
• CHOLESTAGEL Film-Coated Tablets
  ... reduction in LDL-cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone. Cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total and LDL- cholesterol in patients with isolated ...
• OLBETAM
  Olbetam is indicated for the treatment of lipid disorders characterised, according to Fredrickson, by elevated plasma levels of triglycerides (type IV hyperlipo-proteinaemia), or cholesterol (type IIA hyperlipoproteinaemia) and triglycerides and cholesterol (type IIB hyperlipoproteinaemia ...
• LOPID
  ... by hypertriglyceridaemia and/or low HDL-cholesterol. Primary hypercholesterolaemia, particularly when a statin is considered inappropriate or is not tolerated. Primary prevention Reduction of cardiovascular morbidity in males with increased non-HDL cholesterol and at high risk for a first ...
• Gemfibrozil
  ... hypertriglyceridaemia and/or low HDL- cholesterol . Primary hypercholesterolaemia, particularly when a statin is considered inappropriate or is not tolerated. Primary prevention Reduction of cardiovascular morbidity in males with increased non-HDL cholesterol and at high risk for a first ...